5. Challenges
5.1 Competition from Branded Drugs
5.2 Lack of Price-Control
5.3 Weak Supply Chain Management
5.4 Lack of Promotion
5.5 Quality Control
5.6 Lack of Awareness
6. Supply Chain Model
7. Regulatory Landscape
8. India Generic Overview
8.1 Indian Market Performance Relative to the World
8.2 Market Size
8.3 Top Generic Drugs Globally
8.4 Major Generic Segments
9. Consolidations in Generics Industry
10. Government Initiatives
10.1 Jan Aushadhi Scheme for the promotion of Generics Drugs
10.2 Free Essential Drug Scheme
10.3 Telemidicine Initiative “Sehat”
11. Competition
11.1 Market Share of Major Players
11.2 Profiles
11.2.1 Sun Pharma
11.2.2 Cipla Limited
11.2.3 Biocon
11.2.4 Dr. Reddy’s Laboratories
11.2.5 Lupin Ltd.
11.2.6 Aurobindo Pharma Limited
11.2.7 Wockhardt
11.2.8 Zydus Cadila
11.2.9 Glenmark
11.2.10 Jubilant LifeSciences
12. Future Outlook
13. Generic Industry: The Road Ahead
13.1 Opportunities
13.2 Recommendations